Humanigen

-$0.16 (-2.49%) Today
+$0.02 (+0.32%) As of 8:16 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Humanigen and other ETFs, options, and stocks.

About HGEN

Humanigen, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms.

CEO
Cameron Durrant
Employees
10
Headquarters
Burlingame, California
Founded
2000

HGEN Key Statistics

Market Cap
372.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.45M
High Today
$6.43
Low Today
$6.27
Open Price
$6.40
Volume
970.34K
52 Week High
$29.20
52 Week Low
$5.68

HGEN Earnings

-$1.25
-$0.83
-$0.42
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
—
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure